Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
Neuromielite óptica associada ao anticorpo anti-glicoproteína da mielina de oligodendrócitos positivo
CategoryDefinition
Patients with MOG antibodies tended to have a single or a lower number of attacks, whereas patients with AQP4 antibodies were more likely to be prototypical NMO patients, with relapsing disease characterised by severe optic neuritis or longitudinally extensive transverse myelitis attacks. The degree of recovery, measured by Expanded Disability Status Scale (EDSS) and visual acuity, also indicates that patients with MOG antibodies tended to have a better recovery after an attack. However, is it important to emphasize some patients with MOG antibodies experience severe disability after optic neuritis and longitudinally extensive transverse myelitis.